Gann analysis. getting close to major phycological breakout area. Risk captured in red and Reward captured in green. 2021 PT of $12-20.
Many catalysts ahead for VBI vaccines. HBV therapeutic is said to be a potential blockbuster, with sales in the BILLIONS. Data from Brii high dose cohort expected Q1 2021 (current quarter), also Covid...
Stock is at a major point of previous resistance. I would not be surprised at all if BCRX broke through this RED trend line as the company still has so much potential. Next level ~$16 then $20+
Disclosure: I've been in BCRX since $3.50s and am not a financial advisor.